Barbara Yanni - Net Worth and Insider Trading

Barbara Yanni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara Yanni owns 4 companies in total, including Akcea Therapeutics Inc (AKCA) , Vaccinex Inc (VCNX) , and Trevena Inc (TRVN) among others .

Click here to see the complete history of Barbara Yanni’s form 4 insider trades.

Insider Ownership Summary of Barbara Yanni

Ticker	Comapny	Transaction Date	Type of Owner
AKCA	Akcea Therapeutics Inc	2020-10-12	director
VCNX	Vaccinex Inc	2019-05-15	director
TRVN	Trevena Inc	2022-06-09	director
		2021-07-27	director

Barbara Yanni Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barbara Yanni Ownership Network

Ownership Network List of Barbara Yanni

No Data

Ownership Network Relation of Barbara Yanni

Barbara Yanni Owned Company Details

What does Akcea Therapeutics Inc do?

Who are the key executives at Akcea Therapeutics Inc?

Barbara Yanni is the director of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .

Akcea Therapeutics Inc (AKCA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akcea Therapeutics Inc Insider Transactions

No Available Data

What does Vaccinex Inc do?

Who are the key executives at Vaccinex Inc?

Barbara Yanni is the director of Vaccinex Inc. Other key executives at Vaccinex Inc include director & 10 percent owner Albert Friedberg , director & 10 percent owner & President and CEO Maurice Zauderer , and Chief Operating Officer Elizabeth E. Evans .

Vaccinex Inc (VCNX) Insider Trades Summary

Over the past 18 months, Barbara Yanni made no insider transaction in Vaccinex Inc (VCNX). Other recent insider transactions involving Vaccinex Inc (VCNX) include a net purchase of 3,000,282 shares made by Albert Friedberg , a net sale of 4,483 shares made by Van Strydonck, Gerald E. , and a net purchase of 510,000 shares made by Maurice Zauderer .

In summary, during the past 3 months, insiders sold 0 shares of Vaccinex Inc (VCNX) in total and bought 282 shares, with a net purchase of 282 shares. During the past 18 months, 320 shares of Vaccinex Inc (VCNX) were sold and 250,996 shares were bought by its insiders, resulting in a net purchase of 250,676 shares.

Vaccinex Inc (VCNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vaccinex Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Barbara Yanni is the director of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Barbara Yanni is the director of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

Over the past 18 months, Barbara Yanni made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncorus Inc Insider Transactions

No Available Data

Barbara Yanni Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara Yanni. You might contact Barbara Yanni via mailing address: 1018 W. 8th Avenue, Suite A, King Of Prussia Pa 19406.

Discussions on Barbara Yanni

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.